SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011561
Filing Date
2022-06-13
Accepted
2022-06-13 16:21:24
Documents
13
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itos-20220609.htm   iXBRL 8-K 84356
2 EX-99.1 itos-ex99_1.htm EX-99.1 155981
  Complete submission text file 0000950170-22-011561.txt   384527

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itos-20220609_pre.xml EX-101.PRE 9954
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itos-20220609.xsd EX-101.SCH 2522
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itos-20220609_lab.xml EX-101.LAB 13438
7 EXTRACTED XBRL INSTANCE DOCUMENT itos-20220609_htm.xml XML 4706
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39401 | Film No.: 221011884
SIC: 2836 Biological Products, (No Diagnostic Substances)